 NEWARK, Calif., Nov. 4, 2020 PRNewswire -- Protagonist Therapeutics, Inc. Nasdaq: PTGX today reported its financial results for the third quarter ended September 30, 2020, and provided a corporate update. The three clinical assets PTG-300, PN-943 and PTG-200, all discovered through... 